NO153396C - Analogifremgangsmaate for fremstilling av et farmakologisk akseptabelt polymert middel som kan frigi en terapeutisk virkende forbindelse. - Google Patents

Analogifremgangsmaate for fremstilling av et farmakologisk akseptabelt polymert middel som kan frigi en terapeutisk virkende forbindelse.

Info

Publication number
NO153396C
NO153396C NO821898A NO821898A NO153396C NO 153396 C NO153396 C NO 153396C NO 821898 A NO821898 A NO 821898A NO 821898 A NO821898 A NO 821898A NO 153396 C NO153396 C NO 153396C
Authority
NO
Norway
Prior art keywords
polymary
release
agent
preparation
pharmacologically acceptable
Prior art date
Application number
NO821898A
Other languages
English (en)
Norwegian (no)
Other versions
NO821898L (no
NO153396B (no
Inventor
Barnett Sylvain Pitzele
Peter Hadley Jones
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO821898L publication Critical patent/NO821898L/no
Publication of NO153396B publication Critical patent/NO153396B/no
Publication of NO153396C publication Critical patent/NO153396C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO821898A 1981-06-08 1982-06-07 Analogifremgangsmaate for fremstilling av et farmakologisk akseptabelt polymert middel som kan frigi en terapeutisk virkende forbindelse. NO153396C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/271,748 US4374932A (en) 1981-06-08 1981-06-08 5-ASA Drug delivery system

Publications (3)

Publication Number Publication Date
NO821898L NO821898L (no) 1982-12-09
NO153396B NO153396B (no) 1985-12-02
NO153396C true NO153396C (no) 1986-03-12

Family

ID=23036907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821898A NO153396C (no) 1981-06-08 1982-06-07 Analogifremgangsmaate for fremstilling av et farmakologisk akseptabelt polymert middel som kan frigi en terapeutisk virkende forbindelse.

Country Status (13)

Country Link
US (1) US4374932A (fr)
EP (1) EP0066861B1 (fr)
JP (1) JPS57212119A (fr)
AU (1) AU8462282A (fr)
CA (1) CA1200204A (fr)
DE (1) DE3262768D1 (fr)
DK (1) DK253782A (fr)
ES (1) ES8304539A1 (fr)
IE (1) IE53518B1 (fr)
NO (1) NO153396C (fr)
NZ (1) NZ200882A (fr)
PT (1) PT75021B (fr)
ZA (1) ZA823980B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8405924L (sv) * 1984-11-23 1986-05-24 Pharmacia Ab Nya azoforeningar
DE69226197T2 (de) * 1991-11-08 1999-02-11 Somatogen Inc Hämoglobine als arzneimittelabgabesystem
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE60115465T2 (de) 2000-08-29 2006-08-03 Nobex Corp. Immunoregulierende verbindungen, deren derivate und ihre verwendung
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
WO2003020242A1 (fr) * 2001-08-29 2003-03-13 Srl Technologies, Inc. Preparations a liberation prolongee
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
FR2986010A1 (fr) * 2012-01-19 2013-07-26 Biomerieux Sa Detection in vitro de microorganismes presentant une activite azoreductase
EP3079668A1 (fr) 2013-12-09 2016-10-19 Durect Corporation Complexes de principes pharmaceutiquement actifs, complexes de polymères, et compositions et procédés les impliquant
CN108479727A (zh) * 2018-03-20 2018-09-04 中山大学惠州研究院 一种水杨酸改性的苯乙烯聚合物及其吸附回收工业废水中苯胺类组分的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB408676A (en) * 1931-10-17 1934-04-16 Ig Farbenindustrie Ag The manufacture of symmetrically substituted azobenzene compounds
US2697059A (en) * 1951-01-22 1954-12-14 Edwin L Gustus Hydroxy aromatic carboxylate-resin adsorption composition
US2721827A (en) * 1952-08-29 1955-10-25 Edwin L Gustus Composition containing polyamine resin having adsorbed thereon an anion of para-aminosalicylic acid
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3143465A (en) * 1961-06-19 1964-08-04 Wallace & Tiernan Inc Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
SE7905051L (sv) * 1979-06-11 1980-12-12 Pharmacia Ab Nya sulfonamider
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3027013A1 (de) * 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln

Also Published As

Publication number Publication date
CA1200204A (fr) 1986-02-04
PT75021A (en) 1982-07-01
NO821898L (no) 1982-12-09
AU8462282A (en) 1982-12-16
PT75021B (en) 1984-01-04
NO153396B (no) 1985-12-02
JPS57212119A (en) 1982-12-27
DK253782A (da) 1982-12-09
NZ200882A (en) 1985-08-30
ES512897A0 (es) 1983-03-01
ZA823980B (en) 1983-07-27
EP0066861B1 (fr) 1985-03-27
US4374932A (en) 1983-02-22
IE821361L (en) 1982-12-08
IE53518B1 (en) 1988-12-07
DE3262768D1 (de) 1985-05-02
EP0066861A1 (fr) 1982-12-15
ES8304539A1 (es) 1983-03-01

Similar Documents

Publication Publication Date Title
NO153396C (no) Analogifremgangsmaate for fremstilling av et farmakologisk akseptabelt polymert middel som kan frigi en terapeutisk virkende forbindelse.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO162817C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler.
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.